Both in Biotechnology
Coherus Oncology vs Alpha Cognition
Over the past year CHRS returned −30.6% and ACOG returned +31.6%; their daily moves had a correlation of 0.27.
CHRS −30.6% ACOG +31.6%Growth of $1, one year, split-adjusted
| Metric | CHRS | ACOG |
|---|---|---|
| Price | $1.18 | $8.71 |
| Market cap | $182.3M | $189.7M |
| Today | +3.51% | +1.28% |
| 1 month | −16.3% | −4.9% |
| 6 months | −26.3% | +63.7% |
| Year to date | −16.9% | +34.0% |
| 1 year | −21.3% | +23.0% |
| Revenue growth (YoY) | +39.5% | +267.6% |
| Gross margin | 70.4% | 93.6% |
| Net margin | −144.2% | −144.3% |
| P/E (TTM) | — | — |
| Price / sales | 3.6× | 12.4× |
| Net cash | $68.1M | $41.4M |
| Dividend yield | — | — |
| Volatility (60d) | 73.5% | 50.7% |
| Short % of float | 17.5% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).